ARCHIVES

ACS Defends Dialogue, Calls Story “Misleading”.

This article is from The Cancer Letter archive.

Vol. 26 No. 38 | October 20, 2000

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Debate Ban, Black Box And Status Quo of Power Morcellators

July 25, 2014

Diet/Cancer Product ad Seminar Consensus: It’s Okay When Limited To Categories Of Food

November 7, 1986

Firm Buys Rights To NKT Cells From Beth Israel Deaconess.

July 28, 2000

Sharp To Direct New Institute For Brain Research At MIT.

March 3, 2000

In Brief: $7 Mil. Gift allows USC To Expand Gene Therapy; North Carolina Passes Off-Label Drug Legislation

September 3, 1993

Flat NIH Budget Threatens Future Of Research, Universities Say.

March 14, 2008